☰

Morse Faria, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutical Sciences Virginia Commonwealth University, Richmond, VA, United States 
Area:
Pharmacy, Analytical Chemistry
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Huang Y, Del Nagro CJ, Balic K, Mylott WR, Ismaiel OA, Ma E, Faria M, Wheeler AM, Yuan M, Waldron MP, Peay MG, Cortes DF, Roskos L, Liang M, Rosenbaum AI. Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-PSMA PBD Antibody-Drug Conjugate. Analytical Chemistry. PMID 32459957 DOI: 10.1021/Acs.Analchem.0C01187  0.334
2020 Faria M, Ismaiel O, Waltrip J, Mariannino T, Yuan M, Mylott W, Roongta V, Shen J, Kadiya P. LC-MS/MS Method for the Quantitative Determination of Tanespimycin and its Active Metabolite in Human Plasma: Method Validation and Overcoming an Insidious APCI Source Phenomenon Journal of Applied Bioanalysis. 6: 145-163. DOI: 10.17145/Jab.20.015  0.51
2020 Faria M. Addressing Bioanalytical Needs of Antibody-Based Biotherapeutics by LC-MS Journal of Applied Bioanalysis. 6: 7-11. DOI: 10.17145/Jab.20.003  0.468
2019 Liu L, Liu Y, Dai L, Stella C, Faria M, Shao J, Hicks JL, Cortes DF, Mylott WR, Wakshull E, Kaur S, Xu K. Immunoaffinity LC-MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serum. Bioanalysis. PMID 31701759 DOI: 10.4155/Bio-2019-0082  0.513
2019 Faria M, Peay M, Lam B, Ma E, Yuan M, Waldron M, Mylott WR, Liang M, Rosenbaum AI. Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2. Antibodies (Basel, Switzerland). 8. PMID 31544817 DOI: 10.3390/Antib8010011  0.52
2015 Faria M, Halquist MS, Yuan M, Mylott W, Jenkins RG, Karnes HT. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1001: 156-68. PMID 26279007 DOI: 10.1016/J.Jchromb.2015.05.040  0.632
2015 Faria M, Halquist MS, Yuan M, Mylott W, Jenkins RG, Karnes HT. An extended stable isotope-labeled signature peptide internal standard for tracking immunocapture of human plasma osteopontin for LC-MS/MS quantification. Biomedical Chromatography : Bmc. PMID 25919310 DOI: 10.1002/Bmc.3471  0.634
2012 Faria M, Halquist MS, Kindt E, Li W, Karnes HT, O'Brien PJ. Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 907: 13-20. PMID 22995377 DOI: 10.1016/J.Jchromb.2012.08.024  0.622
2012 Li W, Kang X, Kindt KE, Zhang C, Spilker M, Berlinski PJ, Eisenbraun M, Yan Z, Elliott M, Arbuckle JA, Faria M, Karnes HT, O'Brien PJ. Abstract 2841: A simplified approach to measuring thymidine kinase activity in cells, tumors, and blood as a biomarker of tumor proliferative potential Cancer Research. 72: 2841-2841. DOI: 10.1158/1538-7445.Am2012-2841  0.523
Show low-probability matches.